 |
PDBsum entry 2opr
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of k101e mutant HIV-1 reverse transcriptase in complex with gw420867x.
|
|
Structure:
|
 |
Reverse transcriptase/ribonuclease h. Chain: a. Fragment: p66. Engineered: yes. Mutation: yes. P51 rt. Chain: b. Fragment: p51. Engineered: yes.
|
|
Source:
|
 |
HIV-1 m:b_hxb2r. Organism_taxid: 11706. Strain: hxb2 isolate. Gene: gag-pol. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.90Å
|
R-factor:
|
0.232
|
R-free:
|
0.303
|
|
|
Authors:
|
 |
J.Ren,C.E.Nichols,P.P.Chamberlain,K.L.Weaver,S.A.Short,J.H.Chan, J.Kleim,D.K.Stammers
|
|
Key ref:
|
 |
J.Ren
et al.
(2007).
Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
J Med Chem,
50,
2301-2309.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
30-Jan-07
|
Release date:
|
22-May-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chains A, B:
E.C.2.7.7.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B:
E.C.2.7.7.49
- RNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains A, B:
E.C.2.7.7.7
- DNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains A, B:
E.C.3.1.-.-
|
|
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains A, B:
E.C.3.1.13.2
- exoribonuclease H.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
|
 |
 |
 |
 |
 |
Enzyme class 6:
|
 |
Chains A, B:
E.C.3.1.26.13
- retroviral ribonuclease H.
|
|
 |
 |
 |
 |
 |
Enzyme class 7:
|
 |
Chains A, B:
E.C.3.4.23.16
- HIV-1 retropepsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
50:2301-2309
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
|
|
J.Ren,
C.E.Nichols,
P.P.Chamberlain,
K.L.Weaver,
S.A.Short,
J.H.Chan,
J.P.Kleim,
D.K.Stammers.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The selection of drug resistant viruses is a major problem in efforts to combat
HIV and AIDS, hence, new compounds are required. We report crystal structures of
wild-type and mutant HIV-1 RT with bound non-nucleoside (NNRTI) GW420867X, aimed
at investigating the basis for its high potency and improved drug resistance
profile compared to the first-generation drug nevirapine. GW420867X occupies a
smaller volume than many NNRTIs, yet accesses key regions of the binding pocket.
GW420867X has few contacts with Tyr188, hence, explaining the small effect of
mutating this residue on inhibitor-binding potency. In a mutated NNRTI pocket,
GW420867X either remains in a similar position compared to wild-type
(RT(Leu100Ile) and RT(Tyr188Cys)) or rearranges within the pocket
(RT(Lys101Glu)). For RT(Leu100Ile), GW420867X does not shift position, in spite
of forming different side-chain contacts. The small bulk of GW420867X allows
adaptation to a mutated NNRTI binding site by repositioning or readjustment of
side-chain contacts with only small reductions in binding affinity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.A.Delviks-Frankenberry,
G.N.Nikolenko,
and
V.K.Pathak
(2010).
The "Connection" Between HIV Drug Resistance and RNase H.
|
| |
Viruses,
2,
1476-1503.
|
 |
|
|
|
|
 |
S.G.Sarafianos,
B.Marchand,
K.Das,
D.M.Himmel,
M.A.Parniak,
S.H.Hughes,
and
E.Arnold
(2009).
Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition.
|
| |
J Mol Biol,
385,
693-713.
|
 |
|
|
|
|
 |
K.Das,
J.D.Bauman,
A.D.Clark,
Y.V.Frenkel,
P.J.Lewi,
A.J.Shatkin,
S.H.Hughes,
and
E.Arnold
(2008).
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.
|
| |
Proc Natl Acad Sci U S A,
105,
1466-1471.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.De Clercq
(2007).
The design of drugs for HIV and HCV.
|
| |
Nat Rev Drug Discov,
6,
1001-1018.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|